azacitidine and plerixafor

azacitidine has been researched along with plerixafor in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Abboud, C; Cashen, AF; Christ, S; DiPersio, JF; Eades, WC; Fletcher, T; Gehrs, L; Ghobadi, A; Huselton, E; Kulkarni, S; McFarland, K; Rettig, MP; Ritchey, J; Romee, R; Schroeder, MA; Stockerl-Goldstein, K; Trinkaus, K; Uy, GL; Vij, R; Westervelt, P1

Reviews

1 review(s) available for azacitidine and plerixafor

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for azacitidine and plerixafor

ArticleYear
A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes.
    Leukemia & lymphoma, 2021, Volume: 62, Issue:6

    Topics: Azacitidine; Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Myelodysplastic Syndromes

2021

Other Studies

1 other study(ies) available for azacitidine and plerixafor

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023